Therefore, XHP can regulate the PI3K/Akt-related pathway and downstream VEGF protein; promote cell apoptosis; block the cell cycle; inhibit angiogenesis; and then inhibit the proliferation, differentiation, and metastasis of prostate cancer cells. Here, AKT1 is linked to prostate carcinoma.